Nexien Biopharma, Inc.
NXENDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001625288
Nexien Biopharma, Inc. was delisted in 2024; its insiders filed their last Form 4 on May 28, 2024; no institution reported holding it in 13F filings for Q3 2024; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Nexien Biopharma, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Nexien Biopharma, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Greenberg Richard S | Chief Executive Officer | 7,185,193 | May 28, 2024 | 0 |
| Wasoff Evan L | Chief Financial Officer | 6,500,000 | May 28, 2024 | 0 |
| Goldfarb Robert I | Chief Operating Officer | 2,278,000 | Aug 3, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.